Skip to content

Association between dipeptidyl peptidase-4 inhibitor and acute kidney injury

Association between dipeptidyl peptidase-4 inhibitor and acute kidney injury - Dipeptidyl peptidase-4 inhibitor and kidney injury

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000051147
Enrollment
Unknown
Registered
2023-05-24
Start date
2023-05-24
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult with diabetes mellitus

Interventions

None listed

Sponsors

Kaetsu Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adult with diabetes mellitus

Exclusion criteria

Exclusion criteria: Children, transplantation, gestational diabetes, use of DPP4 inhibitors for non-diabetics mellitus, and no outcome assessment for acute kidney injury.

Design outcomes

Primary

MeasureTime frame
Acute kidney injury

Countries

Japan

Contacts

Public ContactSatoru Mitsuboshi

Kaetsu Hospital Department of pharmacy

ccrtyo34057@gmail.com0250-22-4711

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026